文献速递肺栓塞与肺血管病

墨西哥风湿病学会系统性硬化症药物治疗指南第一部分:皮肤病变、间质性肺病与肺动脉高压

Guide from the Colegio Mexicano de Reumatología for the Pharmacological Treatment of Systemic Sclerosis Part 1: Cutaneous Involvement, Interstitial Lung Disease, and Pulmonary Arterial Hypertension
RSS 订阅 · 指南共识 · 肺动脉高压 · 2026-06-10

该指南由墨西哥风湿病学会多学科专家组采用GRADE方法制定,围绕皮肤病变、间质性肺病和肺动脉高压提出26条推荐,并经Delphi共识(同意率≥80%)通过。系统检索共纳入114项研究,评估了糖皮质激素、免疫抑制剂、免疫调节剂、造血干细胞移植和血管扩张剂等药物。

要点

  • 指南采用GRADE方法制定,以灵活的分步治疗算法为核心,强调临床适用性。
  • 共形成26条推荐,经Delphi共识通过,同意标准为≥80%接受率。
  • 评估药物包括糖皮质激素、免疫抑制剂、免疫调节剂、造血干细胞移植和血管扩张剂。

核心结论

  • 该指南为系统性硬化症皮肤病变、间质性肺病和肺动脉高压的药物治疗提供26条推荐,强调根据医疗资源异质性进行情境化决策。

研究设计与样本

  • 指南由风湿科、皮肤科、呼吸科、心肺科和方法学专家组成的多学科专家组制定,采用GRADE方法。
  • 提出10个PICO问题,系统检索PubMed、Cochrane Library、EMBASE和LILACS(2006年至2024年2月)及关键早期文献。
  • 共识别594条记录,最终纳入114项研究进行GRADE评价。

主要发现

  • 评估了糖皮质激素、免疫抑制剂、免疫调节剂、造血干细胞移植和血管扩张剂等药物。
  • 共发布26条推荐,并经过Delphi共识,同意定义为≥80%接受率。

关键数值与推荐

  • Delphi共识同意标准为≥80%接受率。
  • 系统检索时间范围为2006年至2024年2月,共纳入114项研究。

临床怎么用

  • 临床可依据该分步治疗算法,结合本地资源可及性对系统性硬化症相关皮肤、肺间质和肺动脉高压病变进行药物选择。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Reumatol Clin (Engl Ed). 2026 May;22(5):502164. doi: 10.1016/j.reumae.2026.502164. Epub 2026 Jun 10. ABSTRACT Systemic sclerosis (SSc) is a severe autoimmune disease characterized by fibrosis, inflammation, and vasculopathy, with high morbidity and mortality. Cutaneous involvement is an important marker of disease severity, while interstitial lung disease and pulmonary arterial hypertension represent the leading causes of death. This manuscript presents the first national pharmacologic treatment guideline, developed using the GRADE methodology and structured around a flexible, stepwise therapeutic algorithm. Unlike international guidelines, this proposal prioritizes clinical applicability and context-specific decision-making, given the heterogeneity of resources and access to treatments within our healthcare system. The guideline was developed by a multidisciplinary panel including rheumatologists, dermatologists, pulmonologists, cardiopulmonologists, and methodologists. Authors formulated ten PICO questions, and a systematic search was conducted in PubMed, Cochrane Library, EMBASE, and LILACS (2006-February 2024), including key earlier literature. Of 594 records identified, 114 studies were ultimately included after evaluation using the GRADE methodology. Steroids, immunosuppressants, immunomodulators, hematopoietic stem cell transplantation, and vasodilators were assessed. A total of 26 recommendations were issued and subjected to Delphi consensus, with agreement defined as ≥80% acceptance. PMID: 42270533 | DOI: 10.1016/j.reumae.2026.502164

来源:指南共识 · 肺动脉高压,查看原文。版权归原作者所有。

引用

  1. 指南共识 · 肺动脉高压:Guide from the Colegio Mexicano de Reumatología for the Pharmacological Treatment of Systemic Sclerosis Part 1: Cutaneous Involvement, Interstitial Lung Disease, and Pulmonary Arterial Hypertension

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。